AGX817 Sigma-AldrichSARS-CoV-2 Spike Protein S1 (aa 1-674) Recombinant Antigen
Overview
| Replacement Information |
|---|
| References |
|---|
| Product Information | |
|---|---|
| Format | Purified |
| Presentation | Purified protein in DPBS without preservatives, pH 7.4. |
| Quality Level | MQ100 |
| Applications | |
|---|---|
| Application | COVID-19 Spike Protein S1 (aa 1-674) Recombinant Antigen, expressed in HEK293 cells, Cat. No. AGX817 is tested for as Positive Control. |
| Key Applications |
|
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Storage and Shipping Information | |
|---|---|
| Storage Conditions | Stable for 1 year at -70°C. Avoid repeated freeze/thaw cycles |
| Packaging Information | |
|---|---|
| Material Size | 100 μg |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN |
| AGX817 | 04061842605828 |
Documentation
SARS-CoV-2 Spike Protein S1 (aa 1-674) Recombinant Antigen SDS
| Title |
|---|
SARS-CoV-2 Spike Protein S1 (aa 1-674) Recombinant Antigen Certificates of Analysis
| Title | Lot Number |
|---|---|
| SARS-CoV-2 Spike Protein S1 (aa 1-674) Recombinant Antigen - 3845821 | 3845821 |
| SARS-CoV-2 Spike Protein S1 (aa 1-674) Recombinant Antigen - Q3485625 | Q3485625 |


